ArticleThe Journal of biological chemistry2026
Phosphatidylethanolamine binds to human perilipins via a hydrophobic cleft in their 4-helix bundle domain for lipid droplet targeting.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perilipins (PLINs) are a family of proteins that coat the surface of lipid droplets (LDs), the cell's main storage sites for fats, to control their formation, growth, and breakdown. These proteins share a common structure: an N-terminal PAT domain for initial targeting, a central region of repeating helices that insert into the LD surface, and a C-terminal 4-helix bundle for stable anchoring. While the PAT domain binds diacylglycerol to promote LD formation at the endoplasmic reticulum, the conserved 4-helix bundle's lipid-sensing role has remained elusive. Here, we show that this bundle contains a hydrophobic cleft that specifically binds phosphatidylethanolamine (PE), a cone-shaped lipid promoting membrane bending during LD budding, as predicted by AlphaFold3 (alphafoldserver.com) models and confirmed by docking simulations. Binding assays reveal that the isolated bundle strongly attaches to LD-like particles enriched in PE, but mutations closing the cleft block this interaction. In yeast cells, limiting PE reduces PLIN3 localization to LDs, an effect aggravated by cleft mutations but independent of LD size or number. This PE-binding ability is shared by PLIN2, PLIN4, and PLIN5 but missing in PLIN1, matching their structural differences. Overall, our work reveals how the 4-helix bundle lets PLINs detect and adapt to LD surface lipid makeup, explaining their varied cellular roles and opening paths for treatments in fat-storage diseases such as liver steatosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.